Royalty Pharma plc (RPRX) NASDAQ

55.63

+0.77(+1.40%)

Updated at June 09 04:00PM

Currency In USD

Key Executives

Name	Title	Pay	Year Born
Pablo Legorreta	Founder, Chairman of the Board & Chief Executive Officer	44.02M	1963
Terrance Coyne	Executive Vice President & Chief Financial Officer	1.32M	N/A
Christopher Hite	Chairman of Partnering & Investments	1.32M	1967
Marshall Urist	Executive Vice President of Research & Investments	1.32M	1976
James Folmar Reddoch	Executive Vice President of Investments & Chief Scientific Officer	3.4M	1970
Arthur Richard McGivern	Executive Vice President of Investments & Chief Scientific Officer	3.4M	1975
Eric Cornelius Schneider	Senior Vice President & Chief Technology Officer	0	N/A
Sandy Balkin	Senior Vice President of Strategy & Analytics	0	N/A
George Grofik	Senior Vice President and Head of Investor Relations & Communications	0	N/A
Molly Sawaya	Executive Vice President & Head of Human Capital	0	N/A
Sara Klymkowsky	Senior Vice President of Research & Investments	0	N/A
Sam Landsberg	Finance and Treasurer	0	N/A
Kenneth Siming Sun	Senior VP & Head of Asia	0	N/A
Ashwin Pai	Executive Vice President of Investments & Partnering	0	N/A
Lucas Glass	Head of Artificial Intelligence	0	N/A
Scott Raichilson	Chief Accounting Officer	0	N/A

Name

Title

Pay

Year Born

Pablo Legorreta

Founder, Chairman of the Board & Chief Executive Officer

44.02M

1963

Terrance Coyne

Executive Vice President & Chief Financial Officer

1.32M

N/A

Christopher Hite

Chairman of Partnering & Investments

1.32M

1967

Marshall Urist

Executive Vice President of Research & Investments

1.32M

1976

James Folmar Reddoch

Executive Vice President of Investments & Chief Scientific Officer

3.4M

1970

Arthur Richard McGivern

Executive Vice President of Investments & Chief Scientific Officer

3.4M

1975

Eric Cornelius Schneider

Senior Vice President & Chief Technology Officer

N/A

Sandy Balkin

Senior Vice President of Strategy & Analytics

N/A

George Grofik

Senior Vice President and Head of Investor Relations & Communications

N/A

Molly Sawaya

Executive Vice President & Head of Human Capital

N/A

Sara Klymkowsky

Senior Vice President of Research & Investments

N/A

Sam Landsberg

Finance and Treasurer

N/A

Kenneth Siming Sun

Senior VP & Head of Asia

N/A

Ashwin Pai

Executive Vice President of Investments & Partnering

N/A

Lucas Glass

Head of Artificial Intelligence

N/A

Scott Raichilson

Chief Accounting Officer

N/A

Description

Royalty Pharma plc, headquartered in New York City and founded in 1996, operates within the United States as a key player in the biopharmaceutical industry. The company primarily focuses on the acquisition of royalties from biopharmaceutical products and actively invests in funding new developments and innovations in the sector. Its activities involve diligently identifying, evaluating, and securing royalty agreements for a wide array of biopharmaceutical therapies. Beyond acquisitions, Royalty Pharma plc fosters collaborations with various innovators. These partners include academic institutions, research hospitals, non-profit organizations, small and mid-sized biotechnology firms, and larger pharmaceutical companies. The firm's substantial portfolio includes royalty interests in approximately 35 commercially available treatments and an additional 10 product candidates currently in different stages of development. These assets span a diverse range of critical therapeutic areas, such as rare diseases, cancer, neurological conditions, infectious diseases, hematology, and diabetes.